LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015; 65:5-29.
   PubMed Web of Science ®Google Scholar
• Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117:294-9. doi:10.1002/ijc.21183. PMID:15900604
   PubMed Web of Science ®Google Scholar
• Chang A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer. 2011;71:3-10. doi:10.1016/j.lungcan.2010.08.022. PMID:20951465
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-79. doi:10.1038/sj.onc.1206933. PMID:14576837
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G. Systems biology of cisplatin resistance: past, present and future. Cell death & disease. 2014;5:e1257. doi:10.1038/cddis.2013.428
   PubMed Web of Science ®Google Scholar
• Stewart DJ. Mechanisms of resistance to cisplatin and carboplatin. Critical reviews in oncology/hematology. 2007;63:12-31. doi:10.1016/j.critrevonc.2007.02.001. PMID:17336087
   PubMed Web of Science ®Google Scholar
• Tim R. Mercer MEDaJSM. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155-9. doi:10.1038/nrg2521. PMID:19188922
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Gutschner T. Long non-coding RNAs in cancer and development: where do we go from here? International journal of molecular sciences. 2015;16:1395-405. doi:10.3390/ijms16011395. PMID:25580533
   PubMed Web of Science ®Google Scholar
• Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development. DNA repair. 2016;45:25-33. doi:10.1016/j.dnarep.2016.06.003. PMID:27427176
   PubMed Web of Science ®Google Scholar
• Chen QN, Wei CC, Wang ZX, Sun M. Long non-coding RNAs in anti-cancer drug resistance. Oncotarget. 2017;8:1925-36. PMID:27713133
   PubMed Web of Science ®Google Scholar
• Zhou H, Wang F, Chen H, Tan Q, Qiu S, Chen S, Jing W, Yu M, Liang C, Ye S, et al. Increased expression of long‐noncoding RNA ZFAS1 is associated with epithelial‐mesenchymal transition of gastric cancer. Aging (Albany NY). 2016;8:2023-38. doi:10.18632/aging.101048. PMID:27654478
   PubMedGoogle Scholar
• Godinho M, Meijer D, Setyono-Han B, Dorssers LC, van Agthoven T. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. J Cell Physiol. 2011;226:1741-9. doi:10.1002/jcp.22503. PMID:21506106
   PubMed Web of Science ®Google Scholar
• Li X, Zha Q, Ren Z, Tang J, Yao Y. Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA. Curr Opin Oncol. 2015;27:457-65. doi:10.1097/CCO.0000000000000235. PMID:26371779
   PubMed Web of Science ®Google Scholar
• Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao H, Zhong Z, Sun J. Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Oncotarget. 2016;7:32433-48. doi:10.18632/oncotarget.8653. PMID:27074572
   PubMed Web of Science ®Google Scholar
• Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P, Lu B, Liu G, Wang Z. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. PloS one. 2015;10:e0114586. doi:10.1371/journal.pone.0114586. PMID:25992654
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PloS one. 2013;8:e65309. doi:10.1371/journal.pone.0065309. PMID:23741487
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, De W, Wang Z, Wang R. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PloS one. 2013;8:e77293. doi:10.1371/journal.pone.0077293. PMID:24155936
   PubMed Web of Science ®Google Scholar
• Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, Willard HF. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991;349:38-44. doi:10.1038/349038a0. PMID:1985261
   PubMed Web of Science ®Google Scholar
• Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. Journal of experimental & clinical cancer research : CR. 2016;35:142. doi:10.1186/s13046-016-0420-1
   PubMed Web of Science ®Google Scholar
• Ma L, Zhou Y, Luo X, Gao H, Deng X, Jiang Y. Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. Oncotarget. 2017;8:4125-35. PMID:27911852
   PubMed Web of Science ®Google Scholar
• Chang S, Chen B, Wang X, Wu K, Sun Y. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC cancer. 2017;17:248. doi:10.1186/s12885-017-3216-6. PMID:28388883
   PubMed Web of Science ®Google Scholar
• Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1:769-76. PMID:12492109
   PubMed Web of Science ®Google Scholar
• Tantai J, Hu D, Yang Y, Geng J. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int J Clin Exp Pathol. 2015;8:7887-95. PMID:26339353
   PubMed Web of Science ®Google Scholar
• Wang H, Shen Q, Zhang X, Yang C, Cui S, Sun Y, Wang L, Fan X, Xu S. The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2017;41:2221-9. doi:10.1159/000475637. PMID:28448993
   PubMed Web of Science ®Google Scholar
• Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631-40. doi:10.1016/j.cell.2005.10.022. PMID:16271387
   PubMed Web of Science ®Google Scholar
• Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, Hannon GJ. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A. 2007;104:19291-6. doi:10.1073/pnas.0709971104. PMID:18042700
   PubMed Web of Science ®Google Scholar
• Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer gene therapy. 2010;17:523-31. doi:10.1038/cgt.2010.18. PMID:20467450
   PubMed Web of Science ®Google Scholar
• Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008;68:10307-14. doi:10.1158/0008-5472.CAN-08-1954. PMID:19074899
   PubMed Web of Science ®Google Scholar
• Fawzy IO, Hamza MT, Hosny KA, Esmat G, Abdelaziz AI. Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth. Growth factors. 2016;34:42-50. doi:10.3109/08977194.2016.1169532. PMID:27126374
   PubMed Web of Science ®Google Scholar
• Liu K, Qian T, Tang L, Wang J, Yang H, Ren J. Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J Surg Oncol. 2012;10:225. doi:10.1186/1477-7819-10-225. PMID:23107361
   PubMed Web of Science ®Google Scholar
• Zhou H, Li Y, Liu B, Shan Y, Li Y, Zhao L, Su Z, Li J. Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression. Gene. 2017;626:106-18. doi:10.1016/j.gene.2017.05.030.
   Web of Science ®Google Scholar
• Greenhough J, Papadakis ES, Cutress RI, Townsend PA, Oreffo RO, Tare RS. Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1). Scientific reports. 2016;6:33504. doi:10.1038/srep33504. PMID:27633857
   PubMed Web of Science ®Google Scholar
• Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell. 1995;80:279-84. doi:10.1016/0092-8674(95)90410-7. PMID:7834747
   PubMed Web of Science ®Google Scholar
• Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G. BAG-1: a multifunctional regulator of cell growth and survival. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. 2003;1603:83-98. doi:10.1016/S0304-419X(03)00002-7
   PubMed Web of Science ®Google Scholar
• Yang L, McBurney D, Tang SC, Carlson SG, Horton WE, Jr. A novel role for Bcl-2 associated-athanogene-1 (Bag-1) in regulation of the endoplasmic reticulum stress response in mammalian chondrocytes. Journal of cellular biochemistry. 2007;102:786-800. doi:10.1002/jcb.21328. PMID:17546604
   PubMed Web of Science ®Google Scholar
• Wang Y, Ha M, Liu J, Li P, Zhang W, Zhang X. Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer. Oncology letters. 2016;11:984-90. PMID:26893680
   PubMed Web of Science ®Google Scholar
• Liu H, Lu S, Gu L, Gao Y, Wang T, Zhao J, Rao J, Chen J, Hao X, Tang SC. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2014;33:365-74. doi:10.1159/000356676. PMID:24557447
   PubMed Web of Science ®Google Scholar